Antibody polyreactivity in health and disease: Statu variabilis

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 993-999

  Dimitrov, Jordan D ^a,b,c   Planchais, Cyril ^a,b,c   Roumenina, Lubka T ^a,b,c   Vassilev, Tchavdar L ^d   Kaveri, Srinivas V ^a,b,c   Lacroix Desmazes, Sebastien ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN;

ALLERGY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOLOGICAL FUNCTIONS; DISEASE ASSOCIATION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANTIBODIES; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; B-LYMPHOCYTES; EPITOPES; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOGLOBULINS; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, ANTIGEN, B-CELL;

EID: 84880696220     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300880     Document Type: Review

References (80)

1. Paige, C. J., and G. E. Wu. 1989. The B cell repertoire. FASEB J. 3: 1818-1824.
2. Manivel, V., N. C. Sahoo, D. M. Salunke, and K. V. Rao. 2000. Maturation of an antibody response is governed by modulations in flexibility of the antigencombining site. Immunity 13: 611-620.
3. Manivel, V., F. Bayiroglu, Z. Siddiqui, D. M. Salunke, and K. V. S. Rao. 2002. The primary antibody repertoire represents a linked network of degenerate antigen specificities. J. Immunol. 169: 888-897.
4. Michaelides, M. C., and H. N. Eisen. 1974. The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies. J. Exp. Med. 140: 687-702.
5. Haspel, M. V., T. Onodera, B. S. Prabhakar, P. R. McClintock, K. Essani, U. R. Ray, S. Yagihashi, and A. L. Notkins. 1983. Multiple organ-reactive monoclonal autoantibodies. Nature 304: 73-76.
6. Coutinho, A., M. D. Kazatchkine, and S. Avrameas. 1995. Natural autoantibodies. Curr. Opin. Immunol. 7: 812-818.
7. Lacroix-Desmazes, S., S. V. Kaveri, L. Mouthon, A. Ayouba, E. Malanchére, A. Coutinho, and M. D. Kazatchkine. 1998. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J. Immunol. Methods 216: 117-137.
8. Ehrenstein, M. R., and C. A. Notley. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778-786.
9. Notkins, A. L. 2004. Polyreactivity of antibody molecules. Trends Immunol. 25: 174-179.
10. Dimitrov, J. D., A. D. Pashov, and T. L. Vassilev. 2012. Antibody polyspecificity: what does it matter? In Advances in Experimental Medicine and Biology, Vol. 750. H. Lutz, ed. Springer, New York, p. 213-226.
11. Van Regenmortel, M. H. 2012. Basic research in HIV vaccinology is hampered by reductionist thinking. Front. Immunol. 3: 194.
12. Casali, P., and A. L. Notkins. 1989. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu. Rev. Immunol. 7: 513-535.
13. Zhou, Z. H., and A. L. Notkins. 2004. Polyreactive antigen-binding B (PAB+) cells are widely distributed and the PAB+ population consists of both B-1+ and B-12 phenotypes. Clin. Exp. Immunol. 137: 88-100.
14. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
15. Wedemayer, G. J., P. A. Patten, L. H. Wang, P. G. Schultz, and R. C. Stevens. 1997. Structural insights into the evolution of an antibody combining site. Science 276: 1665-1669.
16. Nguyen, H. P., N. O. Seto, C. R. MacKenzie, L. Brade, P. Kosma, H. Brade, and S. V. Evans. 2003. Germline antibody recognition of distinct carbohydrate epitopes. Nat. Struct. Biol. 10: 1019-1025.
17. Jimenez, R., G. Salazar, J. Yin, T. Joo, and F. E. Romesberg. 2004. Protein dynamics and the immunological evolution of molecular recognition. Proc. Natl. Acad. Sci. USA 101: 3803-3808.
18. Ikematsu, H., M. T. Kasaian, E. W. Schettino, and P. Casali. 1993. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J. Immunol. 151: 3604-3616.
19. Ditzel, H. J., K. Itoh, and D. R. Burton. 1996. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection. J. Immunol. 157: 739-749.
20. Tiller, T., M. Tsuiji, S. Yurasov, K. Velinzon, M. C.Nussenzweig, andH.Wardemann. 2007. Autoreactivity in human IgG+ memory B cells. Immunity 26: 205-213.
21. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.
22. Benckert, J., N. Schmolka, C. Kreschel, M. J. Zoller, A. Sturm, B. Wiedenmann, and H. Wardemann. 2011. The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J. Clin. Invest. 121: 1946-1955.
23. Mouquet, H., J. F. Scheid, M. J. Zoller, M. Krogsgaard, R. G. Ott, S. Shukair, M. N. Artyomov, J. Pietzsch, M. Connors, F. Pereyra, et al. 2010. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467: 591-595.
24. Liao, H. X., X. Chen, S. Munshaw, R. Zhang, D. J. Marshall, N. Vandergrift, J. F. Whitesides, X. Lu, J. S. Yu, K. K. Hwang, et al. 2011. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J. Exp. Med. 208: 2237-2249.
25. Ikematsu, H., E. W. Schettino, and P. Casali. 1995. Structure of the VH-D-JH segments of human natural polyreactive IgM and IgG antibodies. Use of germline or somatically mutated forms of commonly expressed VH genes. Ann. N. Y. Acad. Sci. 764: 362-369.
26. Zhou, Z. H., A. G. Tzioufas, and A. L. Notkins. 2007. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J. Autoimmun. 29: 219-228.
27. Schettino, E. W., S. K. Chai, M. T. Kasaian, H. W. Schroeder, Jr., and P. Casali. 1997. VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J. Immunol. 158: 2477-2489.
28. Ichiyoshi, Y., and P. Casali. 1994. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J. Exp. Med. 180: 885-895.
29. Martin, T., R. Crouzier, J. C. Weber, T. J. Kipps, and J. L. Pasquali. 1994. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementaritydetermining region of the antibody heavy chain. J. Immunol. 152: 5988-5996.
30. Padlan, E. A. 1994. Anatomy of the antibody molecule. Mol. Immunol. 31: 169-217.
31. Torres, M., and A. Casadevall. 2008. The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol. 29: 91-97.
32. Torres, M., N. Fernández-Fuentes, A. Fiser, and A. Casadevall. 2007. The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. J. Biol. Chem. 282: 13917-13927.
33. James, L. C., and D. S. Tawfik. 2003. Conformational diversity and protein evolution: a 60-year-old hypothesis revisited. Trends Biochem. Sci. 28: 361-368.
34. Jimenez, R., G. Salazar, K. K. Baldridge, and F. E. Romesberg. 2003. Flexibility and molecular recognition in the immune system. Proc. Natl. Acad. Sci. USA 100: 92-97.
35. Eisen, H. N., and A. K. Chakraborty. 2010. Evolving concepts of specificity in immune reactions. Proc. Natl. Acad. Sci. USA 107: 22373-22380.
36. Foote, J., and C. Milstein. 1994. Conformational isomerism and the diversity of antibodies. Proc. Natl. Acad. Sci. USA 91: 10370-10374.
37. James, L. C., P. Roversi, and D. S. Tawfik. 2003. Antibody multispecificity mediated by conformational diversity. Science 299: 1362-1367.
38. Sethi, D. K., A. Agarwal, V. Manivel, K. V. Rao, and D. M. Salunke. 2006. Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity 24: 429-438.
39. Corper, A. L., M. K. Sohi, V. R. Bonagura, M. Steinitz, R. Jefferis, A. Feinstein, D. Beale, M. J. Taussig, and B. J. Sutton. 1997. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-Antigen interaction. Nat. Struct. Biol. 4: 374-381.
40. Cabiedes, J., A. R. Cabral, and D. Alarcón-Segovia. 1998. Hidden antiphospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments. Eur. J. Immunol. 28: 2108-2114.
41. McMahon, M. J., and R. O'Kennedy. 2000. Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH. J. Immunol. Methods 241: 1-10.
42. Bouvet, J. P., D. Stahl, S. Rose, C. P. Quan, M. D. Kazatchkine, and S. V. Kaveri. 2001. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J. Autoimmun. 16: 163-172.
43. Djoumerska-Alexieva, I. K., J. D. Dimitrov, E. N. Voynova, S. Lacroix-Desmazes, S. V. Kaveri, and T. L. Vassilev. 2010. Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis. FEBS J. 277: 3039-3050.
44. Jones, D. D., G. A. DeIulio, and G. M. Winslow. 2012. Antigen-driven induction of polyreactive IgM during intracellular bacterial infection. J. Immunol. 189: 1440-1447.
45. McIntyre, J. A., D. R. Wagenknecht, and W. P. Faulk. 2006. Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun. Rev. 5: 76-83.
46. Dimitrov, J. D., N. D. Ivanovska, S. Lacroix-Desmazes, V. R. Doltchinkova, S. V. Kaveri, and T. L. Vassilev. 2006. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J. Biol. Chem. 281: 439-446.
47. Dimitrov, J. D., L. T. Roumenina, V. R. Doltchinkova, N. M. Mihaylova, S. Lacroix-Desmazes, S. V. Kaveri, and T. L. Vassilev. 2007. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J. Biol. Chem. 282: 26696-26706.
48. Mihaylova, N. M., J. D. Dimitrov, I. K. Djoumerska-Alexieva, and T. L. Vassilev. 2008. Inflammation-induced enhancement of IgG immunoreactivity. Inflamm. Res. 57: 1-3.
49. Pavlovic, S., N. Zdravkovic, J. D. Dimitrov, A. Djukic, N. Arsenijevic, T. L. Vassilev, and M. L. Lukic. 2011. Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes. Clin. Immunol. 138: 162-171.
50. Tokuriki, N., and D. S. Tawfik. 2009. Protein dynamism and evolvability. Science 324: 203-207.
51. Cohen, I. R. 2006. Immune system computation and the immunological homunculus. Model Driv. Eng. Lang. Systs. Proc. 4199: 499-512.
52. Cohen, I. R. 2007. Real and artificial immune systems: computing the state of the body. Nat. Rev. Immunol. 7: 569-574.
53. Coutinho, A., and S. Avrameas. 1992. Speculations on immunosomatics: potential diagnostic and therapeutic value of immune homeostasis concepts. Scand. J. Immunol. 36: 527-532.
54. Cohen, I. R. 1992. The cognitive paradigm and the immunological homunculus. Immunol. Today 13: 490-494.
55. Wang, Z., Z. J. Chen, J. Wheeler, S. Shen, and A. L. Notkins. 2001. Characterization of murine polyreactive antigen-binding B cells: presentation of antigens to T cells. Eur. J. Immunol. 31: 1106-1114.
56. Notley, C. A., M. A. Brown, G. P. Wright, and M. R. Ehrenstein. 2011. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol. 186: 4967-4972.
57. Binder, C. J. 2012. Naturally occurring IgM antibodies to oxidation-specific epitopes. Adv. Exp. Med. Biol. 750: 2-13.
58. Elkon, K. B., and G. J. Silverman. 2012. Naturally occurring autoantibodies to apoptotic cells. Adv. Exp. Med. Biol. 750: 14-26.
59. Zipfel, P. F., and C. Skerka. 2009. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9: 729-740.
60. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
61. Zhou, Z. H., Y. Zhang, Y. F. Hu, L. M. Wahl, J. O. Cisar, and A. L. Notkins. 2007. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1: 51-61.
62. Warter, L., R. Appanna, and K. Fink. 2012. Human poly-And cross-reactive antiviral antibodies and their impact on protection and pathology. Immunol. Res. 53: 148-161.
63. Ditzel, H. J., S. M. Barbas, C. F. Barbas, III, and D. R. Burton. 1994. The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. USA 91: 3710-3714.
64. Mouquet, H., and M. C. Nussenzweig. 2012. Polyreactive antibodies in adaptive immune responses to viruses. Cell. Mol. Life Sci. 69: 1435-1445.
65. Mouquet, H., F. Klein, J. F. Scheid, M. Warncke, J. Pietzsch, T. Y. Oliveira, K. Velinzon, M. S. Seaman, and M. C. Nussenzweig. 2011. Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses. PLoS ONE 6: e24078.
66. Haynes, B. F., J. Fleming, E. W. St Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R. M. Scearce, K. Plonk, H. F. Staats, et al. 2005. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308: 1906-1908.
67. Yang, G., T. M. Holl, Y. Liu, Y. Li, X. Lu, N. I. Nicely, T. B. Kepler, S. M. Alam, H. X. Liao, D. W. Cain, et al. 2013. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J. Exp. Med. 210: 241-256.
68. Corti, D., and A. Lanzavecchia. 2013. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 31: 705-742.
69. Alam, S. M., M. Morelli, S. M. Dennison, H. X. Liao, R. Zhang, S. M. Xia, S. Rits-Volloch, L. Sun, S. C. Harrison, B. F. Haynes, and B. Chen. 2009. Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc. Natl. Acad. Sci. USA 106: 20234-20239.
70. Diskin, R., P. M. Marcovecchio, and P. J. Bjorkman. 2010. Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Nat. Struct. Mol. Biol. 17: 608-613.
71. Dimitrov, J. D., M. D. Kazatchkine, S. V. Kaveri, and S. Lacroix-Desmazes. 2011. "Rational vaccine design" for HIV should take into account the adaptive potential of polyreactive antibodies. PLoS Pathog. 7: e1002095.
72. Wang, Zq., H. W. Horowitz, T. Orlikowsky, B. I. Hahn, V. Trejo, A. S. Bapat, R. S. Mittler, R. J. Rayanade, S. Y. Yang, and M. K. Hoffmann. 1999. Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function. J. Infect. Dis. 180: 1072-1079.
73. Borche, L., A. Lim, J. L. Binet, and G. Dighiero. 1990. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 76: 562-569.
74. Hervé, M., K. Xu, Y. S. Ng, H. Wardemann, E. Albesiano, B. T. Messmer, N. Chiorazzi, and E. Meffre. 2005. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 115: 1636-1643.
75. Craig, V. J., I. Arnold, C. Gerke, M. Q. Huynh, T. Wündisch, A. Neubauer, C. Renner, S. Falkow, and A. Müller. 2010. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 115: 581-591.
76. Warsame, A. A., H. C. Aasheim, K. Nustad, G. Troen, A. Tierens, V. Wang, U. Randen, H. P. Dong, S. Heim, A. Brech, and J. Delabie. 2011. Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly-And self-reactive antibodies with similar reactivity. Blood 118: 3331-3339.
77. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M. C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201: 703-711.
78. Samuels, J., Y. S. Ng, C. Coupillaud, D. Paget, and E. Meffre. 2005. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 201: 1659-1667.
79. Zhang, J., A. M. Jacobi, T. Wang, R. Berlin, B. T. Volpe, and B. Diamond. 2009. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J. Autoimmun. 33: 270-274.
80. Kashiwakura, J., Y. Okayama, M. Furue, K. Kabashima, S. Shimada, C. Ra, R. P. Siraganian, Y. Kawakami, and T. Kawakami. 2012. Most Highly Cytokinergic IgEs Have Polyreactivity to Autoantigens. Allergy Asthma Immunol. Res. 4: 332-340.